CO5580759A2 - 1-3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion - Google Patents

1-3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion

Info

Publication number
CO5580759A2
CO5580759A2 CO04052091A CO04052091A CO5580759A2 CO 5580759 A2 CO5580759 A2 CO 5580759A2 CO 04052091 A CO04052091 A CO 04052091A CO 04052091 A CO04052091 A CO 04052091A CO 5580759 A2 CO5580759 A2 CO 5580759A2
Authority
CO
Colombia
Prior art keywords
carbon atoms
group
alkyl
substituted
cycle
Prior art date
Application number
CO04052091A
Other languages
English (en)
Spanish (es)
Inventor
Patrick Maillet
Cecile Combeau
Marie-Christ Bissery
Marie-Pierre Cherrier
Thomas Caulfield
Gilles Tiraboschi
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115739A external-priority patent/FR2833008B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of CO5580759A2 publication Critical patent/CO5580759A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Detergent Compositions (AREA)
CO04052091A 2001-12-05 2004-06-03 1-3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion CO5580759A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR0214217 2002-11-14

Publications (1)

Publication Number Publication Date
CO5580759A2 true CO5580759A2 (es) 2005-11-30

Family

ID=26213287

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04052091A CO5580759A2 (es) 2001-12-05 2004-06-03 1-3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion

Country Status (23)

Country Link
EP (1) EP1453790A2 (fr)
JP (1) JP2005531494A (fr)
KR (1) KR20050044712A (fr)
CN (1) CN1612856A (fr)
AR (1) AR037479A1 (fr)
AU (1) AU2002365644A1 (fr)
BR (1) BR0214694A (fr)
CA (1) CA2469193A1 (fr)
CO (1) CO5580759A2 (fr)
EA (1) EA006803B1 (fr)
HR (1) HRP20040508A2 (fr)
HU (1) HUP0500100A2 (fr)
IL (1) IL162223A0 (fr)
MA (1) MA27351A1 (fr)
MX (1) MXPA04005226A (fr)
NZ (1) NZ533224A (fr)
PA (1) PA8558501A1 (fr)
PE (1) PE20030758A1 (fr)
PL (1) PL370676A1 (fr)
RS (1) RS47804A (fr)
SV (1) SV2003001422A (fr)
TW (1) TW200300685A (fr)
WO (1) WO2003048106A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854399B1 (fr) * 2003-04-30 2006-11-17 Aventis Pharma Sa 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
EP1598353A1 (fr) 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones et leur utilisation en tant qu'agents antiproliferatifs
WO2017103637A1 (fr) 2015-12-18 2017-06-22 Blirt S.A. Composés de diphénylpropane et leur activité cytotoxique
CN109467549B (zh) * 2018-12-07 2021-02-09 中国药科大学 喹啉取代查尔酮类化合物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH08277242A (ja) * 1995-02-08 1996-10-22 Kyowa Hakko Kogyo Co Ltd プロペノン誘導体
EP0812825B1 (fr) * 1995-12-01 2004-02-11 Kyowa Hakko Kogyo Co., Ltd. Derives du propenone
AU7908098A (en) * 1997-06-26 1999-01-19 Statens Serum Institut Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones

Also Published As

Publication number Publication date
MXPA04005226A (es) 2004-10-11
BR0214694A (pt) 2004-12-14
EP1453790A2 (fr) 2004-09-08
TW200300685A (en) 2003-06-16
CN1612856A (zh) 2005-05-04
AU2002365644A1 (en) 2003-06-17
JP2005531494A (ja) 2005-10-20
AR037479A1 (es) 2004-11-10
IL162223A0 (en) 2005-11-20
KR20050044712A (ko) 2005-05-12
WO2003048106A2 (fr) 2003-06-12
HUP0500100A2 (hu) 2005-05-30
EA200400764A1 (ru) 2004-12-30
EA006803B1 (ru) 2006-04-28
SV2003001422A (es) 2003-07-10
PA8558501A1 (es) 2003-09-05
PL370676A1 (en) 2005-05-30
MA27351A1 (fr) 2005-06-01
RS47804A (en) 2006-12-15
HRP20040508A2 (en) 2005-08-31
PE20030758A1 (es) 2003-10-07
CA2469193A1 (fr) 2003-06-12
NZ533224A (en) 2006-03-31
WO2003048106A3 (fr) 2004-03-25

Similar Documents

Publication Publication Date Title
CO5540280A2 (es) Derivados aromaticos de acido dicarboxilico
ES2130985B1 (es) Hidroxifeniltriazinas.
NI200600322A (es) Inhibidores de cetp
CO4900062A1 (es) Piridinas condensadas con heterociclos
AR042149A1 (es) Uso de aminas y/o aductos de mannich en composiciones de combustibles y lubricantes para motores otto de inyeccion directa
CO4771105A1 (es) Procedimiento para la preparacion de derivados de la clase de los taxoides
NO20052976L (no) Fosfodiesterase-4-inhibitorer.
CO6160235A2 (es) Isoxazolinas insecticidas
CO5021127A1 (es) Nuevas dihidropirimidas
CO5660262A2 (es) Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
ECSP099546A (es) Nuevos derivados tricíclicos, su procedimiento de preparación
CO5690576A2 (es) Profarmacos de los inhibidores de bomba de protones
EA200800737A1 (ru) Поперечно связанные соединения циклических аминов и средства для борьбы с вредителями
AR040413A1 (es) Heterociclilalquinos activos como herbicidas
AR039601A1 (es) Derivados de nitrosodifenilamina y composiciones farmaceuticas que los comprenden como medicamentos que se pueden utilizar en el tratamiento de patologias que se caracterizan por estres oxidativo
AR053453A1 (es) Derivados de aminoalquil- y amidoalquil-benzopirano substituidos
AR017396A1 (es) Derivados de ciclopenteno, composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de medicamentos utiles como antagonistas del receptor de motilina
AR035196A1 (es) Derivados de guanidina o biguanidina y el uso de los mismos para la fabricacion de medicamentos antivirales y antimicrobianos
CO5580759A2 (es) 1-3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
CO5580834A2 (es) Compuestos basicos lineales que tienen actividad antagonista de nk-2 y sus formulaciones
AR072103A1 (es) Derivados de (piperazinilo con enlaces puente)-1- alcanona, su utilizacion como inhibidores de p75 y composiciones farmaceuticas que los contienen
AR034983A1 (es) Una composicion para la tintura por oxidacion de las fibras queratinicas, un procedimiento de tintura de oxidacion de dichas fibras, un "kit" de tintura de varios compartimentos, un producto coloreado, y un derivado de parafenilendiamina
ES2174803T3 (es) Nuevos rerivados acridinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR031662A1 (es) Nuevos derivados biciclicos de aminopirazinonas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y su utilizacion como inhibidores de proteasas de serina relacionadas con la tripsina
CO6280049A1 (es) Nuevos derivados cromenicos su procedimiento de preparacion y las composiciones framaceuticas que los contienen

Legal Events

Date Code Title Description
FA Application withdrawn